Effects of angiotensin II receptor blockers on dementia (Q37591159)

21 August 2017

1 reference

title

Effects of angiotensin II receptor blockers on dementia (English)

1 reference

21 August 2017

0 references

Masaki Mogi

1

1 reference

PubMed ID

19727113

21 August 2017

Masatsugu Horiuchi

series ordinal

2

1 reference

21 August 2017

1 September 2009

1 reference

21 August 2017

Hypertension Research

1 reference

21 August 2017

32

1 reference

21 August 2017

738-740

1 reference

21 August 2017

9

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2009.110

21 August 2017

0 references

cites work

Global prevalence of dementia: a Delphi consensus study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

National estimates of the quantity and cost of informal caregiving for the elderly with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

Economic considerations in the management of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

The age-dependent relation of blood pressure to cognitive function and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

Angiotensin II type-2 receptor stimulation prevents neural damage by transcriptional activation of methyl methanesulfonate sensitive 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

Prevention of atrial fibrillation by way of abrogation of the renin-angiotensin system: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

Exaggeration of focal cerebral ischemia in transgenic mice carrying human Renin and human angiotensinogen genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

Feasibility of treating prehypertension with an angiotensin-receptor blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

Temporary pretreatment with the angiotensin II type 1 receptor blocker, valsartan, prevents ischemic brain damage through an increase in capillary density

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

Continuous activation of renin-angiotensin system impairs cognitive function in renin/angiotensinogen transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

Amelioration of cognitive impairment in the type-2 diabetic mouse by the angiotensin II type-1 receptor blocker candesartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

Inhibition of cognitive decline in mice fed a high-salt and cholesterol diet by the angiotensin receptor blocker, olmesartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

Diabetic brain damage in hypertension: role of renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

Antihypertensive medication use and incident Alzheimer disease: the Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

Telmisartan prevented cognitive decline partly due to PPAR-gamma activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT 2 receptor and the transcription factor NF‐κB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

7 January 2021

Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

7 January 2021

Signals from the AT2 (angiotensin type 2) receptor of angiotensin II inhibit p21ras and activate MAPK (mitogen-activated protein kinase) to induce morphological neuronal differentiation in NG108-15 cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

7 January 2021

Nitric oxide, a new second messenger involved in the action of angiotensin II on neuronal differentiation of NG108-15 cells.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

7 January 2021

Activation of the AT(2) receptor of angiotensin II induces neurite outgrowth and cell migration in microexplant cultures of the cerebellum

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

7 January 2021

Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta ); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

7 January 2021

Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.110

7 January 2021

Identifiers

DOI

10.1038/HR.2009.110

1 reference

21 August 2017

1 reference

PubMed ID

19727113